Back to Search Start Over

S262: THE COBALT-LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70-TARGETED ALLOGENEIC CRISPR-CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T-CELL MALIGNANCIES

Authors :
S. P. Iyer
R. A. Sica
P. J. Ho
B. Hu
J. Zain
A. Prica
W.-K. Weng
Y. H. Kim
M. S. Khodadoust
M. L Palomba
F. M. Foss
K. Tipton
E. L. Cullingford
Q. He
A. Sharma
S. M. Horwitz
Source :
HemaSphere, Vol 6, Pp 163-164 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Subjects

Subjects :
Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :
English
ISSN :
25729241
Volume :
6
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.58dc7ef513b2466ca7b98689ed5f90a1
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000843940.96598.e2
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details